Same Indication

Insulin Icodec vs Trastuzumab

Insulin Icodec vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Insulin Icodec and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab — 28 days.

Chemical Properties

Type: Insulin Icodec — Protein; Trastuzumab — Antibody.